TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Therapeutic drug monitoring (TDM) combines the quantification of drug concentrations in blood, pharmacological interpretation and treatment guidance. TDM introduces a precision medicine tool in times of increasing awareness of the need for personalized treatment. In neurology and psychiatry, TDM can guide pharmacotherapy for patient subgroups such as children, adolescents, pregnant women, elderly patients, patients with intellectual disabilities, patients with substance use disorders, individuals with pharmacokinetic peculiarities and forensic patients. Clear indications for TDM include lack of clinical response in the therapeutic dose range, assessment of drug adherence, tolerability issues and drug-drug interactions. METHODS: Based upon existing literature, recommended therapeutic reference ranges, laboratory alert levels, and levels of recommendation to use TDM for dosage optimization without specific indications, conversion factors, factors for calculation of dose-related drug concentrations and metabolite-to-parent ratios were calculated. RESULTS: This summary of the updated consensus guidelines by the TDM task force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie offers the practical and theoretical knowledge for the integration of TDM as part of pharmacotherapy with neuropsychiatric agents into clinical routine. CONCLUSIONS: The present guidelines for TDM application for neuropsychiatric agents aim to assist clinicians in enhancing safety and efficacy of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
The Pharmacokinetics of Long-Acting Antipsychotic Medications
Spanarello, S., & Ferla, T. (2014) · Current Clinical Pharmacology · doi:10.2174/15748847113089990051 · Cited by 70
Cited by
Schoretsanitis, G., Spina, E., Hiemke, C., & de Leon, J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1549489 · Cited by 50
Self-citationAntidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence
Cellini, L., De Donatis, D., Zernig, G., De Ronchi, D., Giupponi, G., Serretti, A., Xenia, H., Conca, A., & Florio, V. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000386 · Cited by 24
Self-citationHermans, R. A., Ringeling, L. T., Liang, K., Kloosterboer, S. M., de Winter, B. C. M., Hillegers, M. H. J., Koch, B. C. P., & Dierckx, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04445-6 · Cited by 10
“the quantification of serum drug concentrations for dose optimisation, can help in maximising clinical efficacy while minimising the risk of side effects [15].”
BackgroundAngsterkrankungen und Therapieresistenz: Klinische Empfehlungen und Perspektiven
Zwanzger, P., & Diemer, J. (2019) · Nervenheilkunde · doi:10.1055/a-0961-2589 · Cited by 2
Metadata
- Authors
- Schoretsanitis, G., Paulzen, M., Unterecker, S., Schwarz, M., Conca, A., Zernig, G., Gründer, G., Haen, E., Baumann, P., Bergemann, N., Clement, H. W., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., Havemann-Reinecke, U., Hefner, G., Helmer, R., Janssen, G., Jaquenoud-Sirot, E., Laux, G., Messer, T., Mössner, R., Müller, M. J., Pfuhlmann, B., Riederer, P., Saria, A., Schoppek, B., Silva Gracia, M., Stegmann, B., Steimer, W., Stingl, J. C., Uhr, M., Ulrich, S., Waschgler, R., Zurek, G., & Hiemke, C.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2018-03-01
- Volume
- 19
- Issue
- 3
- Pages
- 162-174
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2792421382
- Cited by
- 146
- References
- 2
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians. https://app.cochat.ai/papers/10.1080/15622975.2018.1439595
- The paper
- Schoretsanitis, G., Paulzen, M., Unterecker, S., Schwarz, M., Conca, A., Zernig, G., Gründer, G., Haen, E., Baumann, P., Bergemann, N., Clement, H. W., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., Havemann-Reinecke, U., Hefner, G., Helmer, R., . . . Hiemke, C. (2018). TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2018.1439595
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.